These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 36759763)
1. Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy. Tu Z; Li K; Ji Q; Huang Y; Lv S; Li J; Wu L; Huang K; Zhu X BMC Cancer; 2023 Feb; 23(1):133. PubMed ID: 36759763 [TBL] [Abstract][Full Text] [Related]
2. Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis. Tu Z; Peng J; Long X; Li J; Wu L; Huang K; Zhu X Front Immunol; 2022; 13():844736. PubMed ID: 35592314 [TBL] [Abstract][Full Text] [Related]
3. Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma. He Z; Yang H; Chen Q; Chen YP; Qin H; He W; Chen Z J Gastrointest Oncol; 2024 Jun; 15(3):890-907. PubMed ID: 38989426 [TBL] [Abstract][Full Text] [Related]
4. TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma. Zhu R; Chen YT; Wang BW; You YY; Wang XH; Xie HT; Jiang FG; Zhang MC BMC Cancer; 2023 Feb; 23(1):146. PubMed ID: 36774490 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y Front Immunol; 2023; 14():1155182. PubMed ID: 37275857 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of the Potential Immune-Related Biomarker Transporter Associated With Antigen Processing 1 That Inhibits Metastasis and Invasion of Ovarian Cancer Cells. Li X; Zeng S; Ding Y; Nie Y; Yang M Front Mol Biosci; 2021; 8():763958. PubMed ID: 34957213 [TBL] [Abstract][Full Text] [Related]
7. Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer. Tabassum A; Samdani MN; Dhali TC; Alam R; Ahammad F; Samad A; Karpiński TM J Mol Med (Berl); 2021 Sep; 99(9):1293-1309. PubMed ID: 34047812 [TBL] [Abstract][Full Text] [Related]
8. Qa-1 Zhang X; Sabio E; Krishna C; Ma X; Wang J; Jiang H; Havel JJ; Chan TA Mol Cancer Res; 2021 Jun; 19(6):1076-1084. PubMed ID: 33674442 [TBL] [Abstract][Full Text] [Related]
9. The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation. Wang ZD; Tian X; Wang Y; Wang JJ; Ye SQ; Huang YQ; Qu YY; Chang K; Shi GH; Ye DW; Gu CY Front Oncol; 2022; 12():1013790. PubMed ID: 36419887 [TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
11. Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy. Zhao Y; Liu Z; Deng K; Qu H; Zhang Q; Zhou P; Yang M; Yang X; Wang H; Li R; Xia J Int Immunopharmacol; 2024 May; 132():111998. PubMed ID: 38593510 [TBL] [Abstract][Full Text] [Related]
12. Predictive role of E2F6 in cancer prognosis and responses of immunotherapy. Gong C; Tu Z; Long X; Liu X; Liu F; Liu J; Zhu X; Li J; Huang K Int Immunopharmacol; 2024 Jan; 127():111302. PubMed ID: 38071912 [TBL] [Abstract][Full Text] [Related]
13. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively. Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K Front Immunol; 2022; 13():837512. PubMed ID: 35401558 [TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy. Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107 [TBL] [Abstract][Full Text] [Related]
15. Potential immunologic and prognostic roles of CHRNA6 in SCLC and pan-cancer. Zhao Q; Wang C; Huang W; Song Z; Lang Y; Zhu X Heliyon; 2024 Oct; 10(19):e38572. PubMed ID: 39398083 [TBL] [Abstract][Full Text] [Related]
16. Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma. Heise R; Amann PM; Ensslen S; Marquardt Y; Czaja K; Joussen S; Beer D; Abele R; Plewnia G; Tampé R; Merk HF; Hermanns HM; Baron JM PLoS One; 2016; 11(1):e0146325. PubMed ID: 26735690 [TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor. Mo Z; Li P; Cao Z; Zhang S Front Immunol; 2021; 12():564948. PubMed ID: 34290693 [TBL] [Abstract][Full Text] [Related]
18. HMME-based PDT restores expression and function of transporter associated with antigen processing 1 (TAP1) and surface presentation of MHC class I antigen in human glioma. Zhang SY; Li JL; Xu XK; Zheng MG; Wen CC; Li FC J Neurooncol; 2011 Nov; 105(2):199-210. PubMed ID: 21520005 [TBL] [Abstract][Full Text] [Related]
19. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing. Li S; Paulsson KM; Sjögren HO; Wang P J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102 [TBL] [Abstract][Full Text] [Related]
20. Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function. Ritz U; Momburg F; Pircher HP; Strand D; Huber C; Seliger B Int Immunol; 2001 Jan; 13(1):31-41. PubMed ID: 11133832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]